Integer Holdings Co. (ITGR) Given Average Recommendation of “Hold” by Brokerages

Integer Holdings Co. (NYSE:ITGR) has earned an average recommendation of “Hold” from the eight ratings firms that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $62.00.

ITGR has been the subject of several recent research reports. Zacks Investment Research downgraded Integer from a “buy” rating to a “hold” rating in a research note on Tuesday, January 23rd. ValuEngine raised Integer from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. TheStreet downgraded Integer from a “b-” rating to a “c+” rating in a research note on Thursday, November 9th. BidaskClub downgraded Integer from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. Finally, Royal Bank of Canada reissued a “neutral” rating on shares of Integer in a research note on Friday, October 27th.

Integer (NYSE:ITGR) opened at $51.00 on Friday. The company has a debt-to-equity ratio of 1.95, a quick ratio of 1.37 and a current ratio of 2.58. The firm has a market capitalization of $1,602.49, a P/E ratio of 80.95, a PEG ratio of 1.06 and a beta of 1.08. Integer has a 52 week low of $30.30 and a 52 week high of $55.20.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.04. The business had revenue of $363.31 million during the quarter, compared to the consensus estimate of $354.83 million. Integer had a return on equity of 11.22% and a net margin of 1.42%. The business’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.83 EPS. research analysts anticipate that Integer will post 2.62 earnings per share for the current year.

In related news, VP Thomas J. Mazza sold 23,123 shares of the stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $46.16, for a total value of $1,067,357.68. Following the completion of the transaction, the vice president now directly owns 26,123 shares of the company’s stock, valued at approximately $1,205,837.68. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Gary J. Haire sold 731 shares of the stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total value of $32,814.59. Following the completion of the transaction, the chief financial officer now directly owns 1,911 shares of the company’s stock, valued at $85,784.79. The disclosure for this sale can be found here. Over the last three months, insiders sold 100,625 shares of company stock valued at $4,694,219. 4.80% of the stock is owned by corporate insiders.

Large investors have recently modified their holdings of the business. California Public Employees Retirement System grew its holdings in Integer by 4.9% in the 2nd quarter. California Public Employees Retirement System now owns 92,700 shares of the medical equipment provider’s stock valued at $4,009,000 after buying an additional 4,300 shares in the last quarter. Piedmont Investment Advisors LLC purchased a new stake in Integer in the 2nd quarter valued at $260,000. Vanguard Group Inc. grew its holdings in Integer by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 2,790,328 shares of the medical equipment provider’s stock valued at $120,682,000 after buying an additional 71,154 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in Integer in the 2nd quarter valued at $284,000. Finally, Macquarie Group Ltd. purchased a new stake in Integer in the 2nd quarter valued at $748,000. Institutional investors own 95.11% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2018/01/28/integer-holdings-co-itgr-given-average-recommendation-of-hold-by-brokerages.html.

About Integer

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply